欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号HU/V/0125/001
药品名称Cevac Mass L
活性成分
    • Infectious Bronchitis Virus 2.8 log10 EID50
剂型Lyophilisate for suspension
上市许可持有人CEVA-Phylaxia Veterinary Biologicals Co. Ltd. H-1107 Budapest, Szállás u. 5. Telephone: +36 1 262 9505 E-Mail: ceva-phylaxia@ceva.com
参考成员国 - 产品名称Hungary (HU)
Cevac Mass L vakcina A.U.V.
互认成员国 - 产品名称
    • Germany (DE)
      Cevac Mass L
    • Denmark (DK)
      Cevac Mass L
    • Belgium (BE)
      Cevac Mass L
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
      Cevac Mass L lyophilisate for suspension
    • Austria (AT)
      CEVAC MASS L Lyophillisat zur Herstellung einer Suspension zur oculonasalen Anwendung für Hühner
    • France (FR)
      CEVAC MASS L
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
      Cevac Mass L
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Cevac Mass L
    • Lithuania (LT)
    • Estonia (EE)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
      CEVAC MASS L lyofilizát pro okulonazální suspenzi pro kura domácího
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
    • Greece (GR)
许可日期2016/02/24
最近更新日期2022/12/06
药物ATC编码
    • QI01AD07 avian infectious bronchitis virus
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase